These results were confirmed by post-mortem IHC that showed the significant reduction in tumor volumes by mNSC-SM7L/S-TRAIL (Fig. 5G), as well as an upregulation in cleaved caspase-3 as revealed by immunostaining (Fig. 5G). This evidence concerns the gene CASP3 and neoplasm.